UNSPSC 51131824: Camostat mesilate or mesylate

This classification denotes a protease inhibitor with the molecular formula C20H22N4O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 451M50A1EQ, chemically known as p-(p-guanidinobenzoyloxy)phenyl acetic acid, n,n-dimethylcarbamoylmethyl ester but more generally known as camostat mesilate, which bears US NIH Compound Identifier 43071. European Medicines Agency schedules Camostat mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01007MIG.

Most nations, for tariff and trade purposes, schedule camostat mesylate under HS 29252900. As of Q4 2014, CAMOSTAT MESYLATE remains US FDA's Preferred Term for this commodity. Camostat mesylate bears US NLM identifiers UMLS ID C0060700 and NCI Concept Code C96364. SMILES: CN(C)C(=O)COC(=O)CC1CCC(CC1)OC(=O)C2CCC(CC2)NC(=N)N.CS(=O)(=O)O.

UNSPSC 51131824 Camostat mesilate or mesylate is a Commodity code, but the source shows no recent state and local procurement activity that aligns with this pharmaceutical ingredient. The single recent opportunity tagged under this code—Sourcewell RFP #061626 for Law Enforcement Equipment, posted May 12, 2026 with a response date of June 16, 2026—concerns equipment procurement for law enforcement agencies and has no connection to camostat mesylate or related pharmaceutical products. The mismatch suggests either a coding error in the opportunity record or that this Commodity code does not reflect active state and local purchasing at present.

Without relevant recent opportunities in the source, no geographic concentration, issuing-body pattern, or scope characterization can be drawn. Any business development effort under this code would require direct outreach to state and local health departments, hospital systems, or pharmaceutical procurement offices to establish market presence, since the available records show no current solicitation activity aligned with camostat mesylate acquisition.